+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Breast Cancer Liquid Biopsy Market 2022-2026

  • ID: 5583781
  • Report
  • April 2022
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Bio Rad Laboratories Inc.
  • Biodesix Inc.
  • Epic Sciences Inc.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • Isogen Life Science BV
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the breast cancer liquid biopsy market and it is poised to grow by $464.12 mn during 2022-2026, accelerating at a CAGR of 16.35% during the forecast period. The report on the breast cancer liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of breast cancer cases, growing focus on personalized medicine for cancer care, and increasing demand for better minimally invasive therapies.

The breast cancer liquid biopsy market analysis includes product segment and geographic landscape.

The breast cancer liquid biopsy market is segmented as below:


By Product

  • Reagent Kits
  • Instruments
  • Services

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the programs to detect breast cancer at the early stages as one of the prime reasons driving the breast cancer liquid biopsy market growth during the next few years. Also, increasing funding or investment for liquid biopsy in breast cancer and technological advancements in the early-stage detection of breast cancer will lead to sizable demand in the market.

The report on the breast cancer liquid biopsy market covers the following areas:

  • Breast cancer liquid biopsy market sizing
  • Breast cancer liquid biopsy market forecast
  • Breast cancer liquid biopsy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast cancer liquid biopsy market vendors that include Bio Rad Laboratories Inc., Biocept Inc., Biodesix Inc., Cardiff Oncology Inc., Epic Sciences Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Johnson and Johnson, Lucence Health Inc., Menarini Silicon Biosystems SpA, MiRXES Pte Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., QIAGEN NV, Sysmex Inostics Inc., and Thermo Fisher Scientific Inc. Also, the breast cancer liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio Rad Laboratories Inc.
  • Biodesix Inc.
  • Epic Sciences Inc.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • Isogen Life Science BV

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product Type
5.1 Market segments
Exhibit 24: Chart on Product Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product Type - Market share 2021-2026 (%)
5.2 Comparison by Product Type
Exhibit 26: Chart on Comparison by Product Type
Exhibit 27: Data Table on Comparison by Product Type
5.3 Reagent kits - Market size and forecast 2021-2026
Exhibit 28: Chart on Reagent kits - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Reagent kits - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Reagent kits - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Reagent kits - Year-over-year growth 2021-2026 (%)
5.4 Instruments - Market size and forecast 2021-2026
Exhibit 32: Chart on Instruments - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Instruments - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Instruments - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Instruments - Year-over-year growth 2021-2026 (%)
5.5 Services - Market size and forecast 2021-2026
Exhibit 36: Chart on Services - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Services - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Services - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Services - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Product Type
Exhibit 40: Market opportunity by Product Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Bio Rad Laboratories Inc.
Exhibit 89: Bio Rad Laboratories Inc. - Overview
Exhibit 90: Bio Rad Laboratories Inc. - Business segments
Exhibit 91: Bio Rad Laboratories Inc. - Key news
Exhibit 92: Bio Rad Laboratories Inc. - Key offerings
Exhibit 93: Bio Rad Laboratories Inc. - Segment focus
10.4 Biodesix Inc.
Exhibit 94: Biodesix Inc. - Overview
Exhibit 95: Biodesix Inc. - Product/Service
Exhibit 96: Biodesix Inc. - Key offerings
10.5 F. Hoffmann La Roche Ltd.
Exhibit 97: F. Hoffmann La Roche Ltd. - Overview
Exhibit 98: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 99: F. Hoffmann La Roche Ltd. - Key news
Exhibit 100: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 101: F. Hoffmann La Roche Ltd. - Segment focus
10.6 Fluxion Biosciences Inc.
Exhibit 102: Fluxion Biosciences Inc. - Overview
Exhibit 103: Fluxion Biosciences Inc. - Product/Service
Exhibit 104: Fluxion Biosciences Inc. - Key offerings
10.7 Guardant Health Inc.
Exhibit 105: Guardant Health Inc. - Overview
Exhibit 106: Guardant Health Inc. - Product/Service
Exhibit 107: Guardant Health Inc. - Key news
Exhibit 108: Guardant Health Inc. - Key offerings
10.8 Illumina Inc.
Exhibit 109: Illumina Inc. - Overview
Exhibit 110: Illumina Inc. - Business segments
Exhibit 111: Illumina Inc. - Key news
Exhibit 112: Illumina Inc. - Key offerings
Exhibit 113: Illumina Inc. - Segment focus
10.9 Menarini Silicon Biosystems SpA
Exhibit 114: Menarini Silicon Biosystems SpA - Overview
Exhibit 115: Menarini Silicon Biosystems SpA - Product/Service
Exhibit 116: Menarini Silicon Biosystems SpA - Key offerings
10.10 Myriad Genetics Inc.
Exhibit 117: Myriad Genetics Inc. - Overview
Exhibit 118: Myriad Genetics Inc. - Business segments
Exhibit 119: Myriad Genetics Inc. - Key offerings
Exhibit 120: Myriad Genetics Inc. - Segment focus
10.11 QIAGEN NV
Exhibit 121: QIAGEN NV - Overview
Exhibit 122: QIAGEN NV - Product/Service
Exhibit 123: QIAGEN NV - Key news
Exhibit 124: QIAGEN NV - Key offerings
10.12 Thermo Fisher Scientific Inc.
Exhibit 125: Thermo Fisher Scientific Inc. - Overview
Exhibit 126: Thermo Fisher Scientific Inc. - Business segments
Exhibit 127: Thermo Fisher Scientific Inc. - Key news
Exhibit 128: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 129: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 130: Inclusions checklist
Exhibit 131: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 132: Currency conversion rates for US$
11.4 Research methodology
Exhibit 133: Research methodology
Exhibit 134: Validation techniques employed for market sizing
Exhibit 135: Information sources
11.5 List of abbreviations
Exhibit 136: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Product Type - Market share 2021-2026 (%)
Exhibits 25: Data Table on Product Type - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Product Type
Exhibits 27: Data Table on Comparison by Product Type
Exhibits 28: Chart on Reagent kits - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Reagent kits - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Reagent kits - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Reagent kits - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Instruments - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Instruments - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Instruments - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Instruments - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Services - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Services - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Services - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Services - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by Product Type ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity By Geographical Landscape ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Bio Rad Laboratories Inc. - Overview
Exhibits 90: Bio Rad Laboratories Inc. - Business segments
Exhibits 91: Bio Rad Laboratories Inc. - Key news
Exhibits 92: Bio Rad Laboratories Inc. - Key offerings
Exhibits 93: Bio Rad Laboratories Inc. - Segment focus
Exhibits 94: Biodesix Inc. - Overview
Exhibits 95: Biodesix Inc. - Product/Service
Exhibits 96: Biodesix Inc. - Key offerings
Exhibits 97: F. Hoffmann La Roche Ltd. - Overview
Exhibits 98: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 99: F. Hoffmann La Roche Ltd. - Key news
Exhibits 100: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 101: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 102: Fluxion Biosciences Inc. - Overview
Exhibits 103: Fluxion Biosciences Inc. - Product/Service
Exhibits 104: Fluxion Biosciences Inc. - Key offerings
Exhibits 105: Guardant Health Inc. - Overview
Exhibits 106: Guardant Health Inc. - Product/Service
Exhibits 107: Guardant Health Inc. - Key news
Exhibits 108: Guardant Health Inc. - Key offerings
Exhibits 109: Illumina Inc. - Overview
Exhibits 110: Illumina Inc. - Business segments
Exhibits 111: Illumina Inc. - Key news
Exhibits 112: Illumina Inc. - Key offerings
Exhibits 113: Illumina Inc. - Segment focus
Exhibits 114: Menarini Silicon Biosystems SpA - Overview
Exhibits 115: Menarini Silicon Biosystems SpA - Product/Service
Exhibits 116: Menarini Silicon Biosystems SpA - Key offerings
Exhibits 117: Myriad Genetics Inc. - Overview
Exhibits 118: Myriad Genetics Inc. - Business segments
Exhibits 119: Myriad Genetics Inc. - Key offerings
Exhibits 120: Myriad Genetics Inc. - Segment focus
Exhibits 121: QIAGEN NV - Overview
Exhibits 122: QIAGEN NV - Product/Service
Exhibits 123: QIAGEN NV - Key news
Exhibits 124: QIAGEN NV - Key offerings
Exhibits 125: Thermo Fisher Scientific Inc. - Overview
Exhibits 126: Thermo Fisher Scientific Inc. - Business segments
Exhibits 127: Thermo Fisher Scientific Inc. - Key news
Exhibits 128: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 129: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 130: Inclusions checklist
Exhibits 131: Exclusions checklist
Exhibits 132: Currency conversion rates for US$
Exhibits 133: Research methodology
Exhibits 134: Validation techniques employed for market sizing
Exhibits 135: Information sources
Exhibits 136: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bio Rad Laboratories Inc.
  • Biodesix Inc.
  • Epic Sciences Inc.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • Isogen Life Science BV
The publisher recognizes the following companies as the key players in the global breast cancer liquid biopsy market: Bio Rad Laboratories Inc., Biocept Inc., Biodesix Inc., Cardiff Oncology Inc., Epic Sciences Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Johnson and Johnson, Lucence Health Inc., Menarini Silicon Biosystems SpA, MiRXES Pte Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., QIAGEN NV, Sysmex Inostics Inc., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is programmed to detect breast cancer at the early stages."

According to the report, one of the major drivers for this market is the growing prevalence of breast cancer cases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bio Rad Laboratories Inc.
  • Biocept Inc.
  • Biodesix Inc.
  • Cardiff Oncology Inc.
  • Epic Sciences Inc.
  • Exact Sciences Corp.
  • F. Hoffmann La Roche Ltd.
  • Fluxion Biosciences Inc.
  • Guardant Health Inc.
  • Illumina Inc.
  • Isogen Life Science BV
  • Johnson and Johnson
  • Lucence Health Inc.
  • Menarini Silicon Biosystems SpA
  • MiRXES Pte Ltd.
  • Myriad Genetics Inc.
  • NeoGenomics Laboratories Inc.
  • QIAGEN NV
  • Sysmex Inostics Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown